-
1Academic Journal
Authors: Mariam S. Shamsutdinova, Yulia A. Alymova, Andrey Yu. Vashura, М. С. Шамсутдинова, Ю. А. Алымова, А. Ю. Вашура
Contributors: The article has been published with the support of PROGRESS JSC., Статья опубликована при поддержке ОАО «ПРОГРЕСС».
Source: Current Pediatrics; Том 17, № 6 (2018); 490-495 ; Вопросы современной педиатрии; Том 17, № 6 (2018); 490-495 ; 1682-5535 ; 1682-5527
Subject Terms: энтеральное питание, oncology, juvenile myelomonocytic leukaemia, nutritional status, nutritional support, enteral nutrition, онкология, ювенильный миеломоноцитарный лейкоз, нутритивный статус, нутритивная поддержка
File Description: application/pdf
Relation: https://vsp.spr-journal.ru/jour/article/view/1981/843; Arber DA, Orazi A, Hasserjian R, et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016;127(20):2391–2405. doi:10.1182/blood-2016-03-643544.; Passmore SJ, Chessells JM, Kempski H, et al. Paediatric myelodysplastic syndromes and juvenile myelomonocytic leukaemia in the UK: a population-based study of incidence and survival. Br J Haematol. 2003;121(5):758–767. doi:10.1046/j.1365-2141.2003.04361.x.; Масчан М.А., Хачатрян Л.А., Скворцова Ю.В., и др. Трансплантация гемопоэтических стволовых клеток при ювенильном миеломоноцитарном лейкозе: анализ опыта одного центра и обзор литературы // Онкогематология. — 2011. — Т. 6. — № 1 — С. 45–56.; Kapucu S, Karacan Y. Physiological problems in patients undergoing autologous and allogeneic hematopoietic stem cell transplantation. Asia Pac J Oncol Nurs. 2014;1(1):50–54. doi:10.4103/2347-5625.135821.; Bauer J, Jurgens H, Fruhwald MC. Important aspects of nutrition in children with cancer. Adv Nutr. 2011;2(2):67–77. doi:10.3945/an.110.000141.; Brinksma A, Huizinga G, Sulkers E, et al. Malnutrition in childhood cancer patients: a review on its prevalence and possible causes. Crit Rev Oncol Hematol. 2012;83(2):249–275. doi:10.1016/j.critre vonc.2011.12.003.; Viana MB, Murao M, Ramos G, et al. Malnutrition as a prognostic factor in lymphoblastic leukaemia: a multivariate analysis. Arch Dis Child. 1994;71(4):304–310. doi:10.1136/adc.71.4.304.; Hough R, Vora A. Crisis management in the treatment of childhood acute lymphoblastic leukemia: putting right what can go wrong (emergency complications of disease and treatment). Hematology Am Soc Hematol Educ Program. 2017;2017(1):251–258. doi:10.1182/asheducation-2017.1.251.; WHO. WHO child growth standards: length/height-for-age, weight-for-age, weight-for-length, weight-forheight and body mass index-for-age: methods and development [Internet]. France: WHO; 2006. p. 312 [cited 2018 Nov 15]. Available at: https://www.who.int/childgrowth/standards/technical_report/en/.; Gangadharan A, Choi SE, Hassan A, et al. Protein calorie malnutrition, nutritional intervention and personalized cancer care. Oncotarget. 2017;8(14):24009–24030. doi:10.18632/oncotarget.15103.; van der Linden NC, Kok A, Leermakers-Vermeer MJ, et al. Indicators for enteral nutrition use and prophylactic percutaneous endoscopic gastrostomy placement in patients with head and neck cancer undergoing chemoradiotherapy. Nutr Clin Pract. 2017;32(2):225–232. doi:10.1177/0884533616682684.; Bosaeus I. Nutritional support in multimodal therapy for cancer cachexia. Support Care Cancer. 2008;16(5):447–451. doi:10.1007/s00520-007-0388-7.; Nassereddine S, Rafei H, Elbahesh E, Tabbara I. Acute graft versus host disease: a comprehensive review. Anticancer Res. 2017;37(4):1547–1555. doi:10.21873/anticanres.11483.; Najafi S, Haghighat S, Raji Lahiji M, et al. Randomized study of the effect of dietary counseling during adjuvant chemotherapy on chemotherapy induced nausea and vomiting, and quality of life in patients with breast cancer. Nutr Cancer. 2018:1–10. doi:10.1080/01635581.2018.1527375.; Cohen J, Wakefield CE, Laing DG. Smell and taste disorders resulting from cancer and chemotherapy. Curr Pharm Des. 2016;22(15):2253–2263. doi:10.2174/1381612822666160216150812.
-
2Academic Journal
Source: Russian Journal of Pediatric Hematology and Oncology; Том 5, № 3 (2018); 23-35 ; Российский журнал детской гематологии и онкологии (РЖДГиО); Том 5, № 3 (2018); 23-35 ; 2413-5496 ; 2311-1267 ; 10.17650/2311-1267-2018-5-3
Subject Terms: аллогенная трансплантация гемопоэтических стволовых клеток, hematology, myelodysplastic syndrome, juvenile myelomonocytic leukemia, allogeneic transplantation of hematopoietic stem cells, гематология, миелодиспластический синдром, ювенильный миеломоноцитарный лейкоз
File Description: application/pdf
Relation: https://journal.nodgo.org/jour/article/view/403/396; Fisher W.B., Armentrout S.A., Weisman R. Jr, Graham R.C. Jr. “Preleukemia”. A myelodysplastic syndrome often terminating in acute leukemia. Arch Intern Med 1973;132(2):226–32. PMID: 4515834.; Randall D.L., Reiquam C.W., Githens J.H., Robinson A. Familial myeloproliferative disease. A new syndrome closely simulating myelogenous leukemia in childhood. Am J Dis Child 1965;110(5):479–500. PMID: 5215211.; Bennett J.M., Catovsky D., Daniel M.T. et al. Proposals for the classification of the myelodysplastic syndromes. Br J Haematol 1982;51(2):189–99. PMID: 6952920.; Kleihauer E. The preleukemic syndromes (hematopoietic dysplasia) in childhood. Eur J Pediatr 1980;133(1):5–10. PMID: 6986269.; Тиранова С.А., Алексеев Н.А., Петрова Э.М. и др. К вопросу о существовании гемопоэтических дисплазий (прелейкемий) у детей. Терапевтический архив 1982;8:1–16.; Arber D., Orazi A., Hasserjian R. et al. The 2016 revision to the World Health Organization classification of myelod neoplasms and acute leukemia. Blood 2016;127(20):2391–405. doi:10.1182/blood-2016-03-643544.; Hasle H., Baumann I., Bergstrasser E. et al.; European Working Group on childhood MDS. The International Prognostic Scoring System (IPSS) for childhood myelodysplastic syndrome (MDS) and juvenile myelomonocytic leukemia (JMML). Leukemia 2004;18(12):2008–14. doi:10.1038/sj.leu.2403489.; Hasle H. Myelodysplastic and myeloproliferative disorders of childhood. Hematology Am Soc Hematol Educ Program 2016;2016(1):598–604. doi:10.1182/asheducation-2016.1.598.; West A., Godley L., Churpek J.E. Familial myelodysplastic syndrome/acute leukemia syndromes: a review and utility for translational investigations. Ann N Y Acad Sci 2014;1310:111–8. doi:10.1111/nyas.12346.; Bannon A., DiNardo C. Hereditary predispositopn to myelodysplastic syndrome. Int J Mol Sci 2016;17(6). pii: E838. doi:10.3390/ijms17060838.; Babushok D.V., Bessler M., Olson T.S. Genetic predisposition to myelodysplastic syndrome and acute myeloid leukemia in children and young adults. Leuk Lymphoma 2016;57(3):520–36. doi:10.3109/10428194.2015.1115041.; Swerdlow S.H., Campo E., Harris N.L. et al. WHO classification of tumors of haematopoietic and lymphoid tissues. Lyon, France: IARC Press, 2008.; Babushok D.V., Bessler M. Genetic predisposition syndromes: when should they be considered in the work-up of MDSβ Best Pract Res Clin Haematol 2015;28(1):55–68. doi:10.1016/j.beha.2014.11.004.; Locatelli F., Niemeyer C.M. How I treat juvenile myelomonocytic leukemia. Blood 2015;125(7):1083–90. doi:10.1182/blood-2014-08-550483.; Waespe N., Van Den Akker M., Klaassen R.J. et al. Response to treatment with azacitidine in children with advanced myelodysplastic syndrome prior to hematopoietic stem cell transplantation. Haematologica 2016;101(12):1508–15. doi:10.3324/haematol.2016.145821.; Poetsch A.R., Lipka D.B., Witte T. et al. RASA4 undergoes DNA hypermethylation in resistant juvenile myelomonocytic leukemia. Epigenetics 2014;9(9):1252–60. doi:10.4161/epi.29941.; Malcovati L., Karimi M., Papaemmanuil E. et al. SF3B1 mutation identifies a distinct subset of myelodysplastic syndrome with ring sideroblasts. Blood 2015;126(2):233–41. doi:10.1182/blood-2015-03-633537.; McKerrell Т., Park N., Moreno T. et al. Leukemia-associated somatic mutations drive distinct patterns of age-related clonal hemopoiesis. Cell Rep 2015;10(8);1239-45. doi:10.1016/j.celrep.2015.02.005.; Niemeyer C., Baumann I. Classification of childhood aplastic anemia and myelodysplastic syndrome. Hematology Am Soc Hematol Educ Program 2011;2011:84–9. doi:10.1182/asheducation-2011.1.84.; Kristinsson S.Y., Bjorkholm M., Hultcrantz M. et al. Chronic immune stimulation might act as a trigger for the development of acute myeloid leukemia or myelodysplastic syndromes. J Clin Oncol 2011;29(21):2897–903. doi:10.1200/JCO.2011.34.8540.; Glenthoj A., Orskov A.D., Hansen J.W. et al. Immune mechanisms in myelodysplastic syndrome. Int J Mol Sci. 2016 Jun 15;17(6). pii: E944. doi:10.3390/ijms17060944.; Flores-Figueroa E., Arana-Trejo R.M., Gutierrez-Espindola G. et al. Mesenchymal stem cells in myelodysplastic syndromes: phenotypic and cytogenetic characterization. Leuk Res 2005;29(2):215–24. doi:10.1016/j.leukres.2004.06.011.; Aanei C., Flandrin P., Eloae F.Z. et al. Intrinsic growth deficiencies of mesenchymal stromal cells in myelodysplastic syndromes. Stem Cells Dev 2012;21(10):1604–15. doi:10.1089/scd.2011.0390.; Flores-Figuerova E., Varma S., Montgomery K. et al. Distinctive contact between CD34+ hematopoietic progenitors and CXCL12+ CD271+ mesenchymal stromal cells in benign and myelodysplastic bone marrow. Lab Invest 2012;92(9):1330–41. doi:10.1038/labinvest.2012.93.; Flores-Figuerova E., Montesinos J., Flores-Guzman P. et al. Functional analysis of myelodysplastic syndromes-derived mesenchymal stem cells. Leuk Res 2008;32(9):1407–16. doi:10.1016/j.leukres.2008.02.013.; Soenen-Cornu V., Tourino C., Bonnet M. et al. Mesenchymal cells generated from patients with myelodysplastic syndromes are devoid of chromosomal clonal markers and support short- and long-term hematopoiesis in vitro. Oncogene 2005;24(15):2441–8. doi:10.1038/sj.onc.1208405.; Medyouf H., Mossner M., Jann J. et al. Myelodysplastic cells in patients reprogram mesenchymal stromal cells to establish a transplantable stem cell niche disease unit. Cell Stem Cell 2014;14(6):824–37. doi:10.1016/j.stem.2014.02.014.; Kastrinaki M., Pontikoglou C., Klaus M. et al. Biologic characteristics of bone marrow mesenchymal stem cells in myelodysplastic syndromes. Curr Stem Cell Res Ther 2011;6(2):122–30. PMID: 20528751.; Bulycheva E., Rauner M., Medyouf H. et al. Myelodysplasia is in the niche: novel concepts and emerging therapies. Leukemia 2015;29(2):259–68. doi:10.1038/leu.2014.325.; Abbas S., Kini A., Srivastava V. et al. Coexistence of aberrant hematopoietic and stromal elements in myelodysplastic syndromes. Blood Cells Mol Dis 2017;66:37–46. doi:10.1016/j.bcmd.2017.08.004.; Кулагин А.Д. Клиникогематологические и иммунологические критерии долгосрочного прогноза приобретенной апластической анемии. Автореф. дис. … докт. мед. наук. СПб., 2015. 60 с.; Allegra A., Innao V., Penna G. et al. Telomerase and telomere biology in hematological diseases: A new therapeutic target. Leuk Res 2017;56:60–74. doi:10.1016/j.leukres.2017.02.002.; Wang L., Xiao H., Zhang X. et al. The role of telomeres and telomerase in hematologic malignancies and hematopoietic stem cell transplantation. J Hematol Oncol 2014;7:61. doi:10.1186/s13045-014-0061-9.; Hasle H., Niemeyer C.M., Chessells J.M. et al. A pediatric approach to the WHO classification of myelodysplactic and myeloproliferative diseases. Leukemia 2003;17(2):277–82. doi:10.1038/sj.leu.2402765.; Vardiman J., Thiele J., Arber D. et al. The 2008 revision of the WHO classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood 2009;114(5):937–51. doi:10.1182/blood-2009-03-209262.; Hasegawa D. The current perspective of low-grade myelodysplastic syndrome in children. Int J Hematol 2016;103(4):360–4. doi:10.1007/s12185-016-1965-7.; Осипова А.А., Семенова Е.В., Морозова Е.В. и др. Эффективность трансплантации гемопоэтических стволовых клеток с различными по интенсивности режимами кондиционирования у детей и подростков с миелодиспластическим синдромом. Российский журнал детской гематологии и онкологии 2017;4(2):70–7. doi:10.17650/2311-1267-2017-4-2-70-77.; Масчан М.А., Хачатрян Л.А., Скворцова Ю.В. и др. Трансплантация гемопоэтических стволовых клеток при ювенильном миеломоноцитарном лейкозе: анализ опыта одного центра и обзор литературы. Онкогематология 2011;(1):45–55.; Castleberry R., Emanuel P., Zuckerman K. et al. A pilot study of isotretinoin in the treatment of juvenile chronic myelogenous leukemia. N Engl J Med 1994;331(25):1680–4. doi:10.1056/NEJM199412223312503.; Хачатрян Л.А., Масчан М.А., Самочатова Е.В. и др. Дифференцировочная терапия с использованием 13-цис-Ретиноевой кислоты и низких доз цитозин-арабинозида у детей с ювенильным миеломоноцитарным лейкозом. Онкогематология 2008;(1–2):34–8.; Bergstraesser E., Hasle H., Rogge T. et al. Non-hematopoietic stem cell transplantation treatment of juvenile myelomonocytic leukemia: a retrospective analysis and definition of response criteria. Pediatr Blood Cancer 2007;49(5):629–33. doi:10.1002/pbc.21038.; Овечкина В.Н., Бондаренко С.Н., Морозова Е.В. и др. Острый миелобластный лейкоз и миелодиспластический синдром: применение азацитидина с профилактической и превентивной целью после аллогенной трансплантации гемопоэтических стволовых клеток. Клиническая онкогематология 2017;10(1):45–55.; Yang H., Bueso-Ramos C., DiNardo C. et al. Expression of PD-L1, PD-L2, PD-1 and CTLA4 in myelodysplastic syndromes is enhanced by treatment with hypomethylating agents. Leukemia 2014;28(6):1280–8. doi:10.1038/leu.2013.355.; Locatelli F., Nollke Р., Zecca M. et al.; European Working Group on Childhood MDS; European Blood and Marrow Transplantation Group. Hematopoietic stem cell transplantation (HSCT) in children with juvenile myelomonocytic leukemia (JMML): results of the EWOG-MDS/EBMT trial. Blood 2005;105(1):410–9. doi:10.1182/blood-2004-05-1944.; Phillips C.L., Davies S.M., McMasters R. et al. Low dose decitabine in very high risk relapsed or refractory acute myeloid leukaemia in children and young adults. Br J Haematol 2013;161(3):406–10. doi:10.1111/bjh.12268.; Cseh A., Niemeyer C.M., Yoshimi A. et al. Bridging to transplant with azacitidine in juvenile myelomonocytic leukemia: a retrospective analysis of the EWOG-MDS study group. Blood 2015;125(14):2311–3. doi:10.1182/blood-2015-01-619734.; https://journal.nodgo.org/jour/article/view/403
-
3Academic Journal
Source: Russian Journal of Pediatric Hematology and Oncology; № 1 (2014); 75-79 ; Российский журнал детской гематологии и онкологии (РЖДГиО); № 1 (2014); 75-79 ; 2413-5496 ; 2311-1267 ; 10.17650/2311-1267-2014-0-1
Subject Terms: экулизумаб, haematopoietic stem cell transplantation, juvenile myelomonocytic leukemia, cyclophosphamide, rituximab, bortezomib, eculizumab, трансплантация гемопоэтических стволовых клеток, ювенильный миеломоноцитарный лейкоз, циклофосфамид, ритуксимаб, бортезомиб
File Description: application/pdf
Relation: https://journal.nodgo.org/jour/article/view/17/13; Alba P., Karim M. Y., Hunt B. J. Mycophenolate mofetil as a treatment for autoimmune haemolytic anaemia in patients with systemic lupus erythematosus and antiphospholipid syndrome. Lupus 2003;12 (8):633–5.; Bass G. F., Tuscano E. T., Tuscano J. M. Diagnosis and classification of autoimmune hemolytic anemia. Autoimmun Rev 2014;13(4–5):560–4.; Baudino L., Nimmerjahn F., Azeredo da Silveira S. et al. Differential contribution of three activating IgG Fc receptors (FcgammaRI, FcgammaRIII, and FcgammaRIV) to IgG2a- and IgG2b-induced autoimmune hemolytic anemia in mice. J Immunol 2008;180(3):1948–53.; Chen F. E., Owen I., Savage D. et al. Late onset haemolysis and red cell autoimmunisation after allogeneic bone marrow transplant. Bone Marrow Transplant 1997;19(5):491–5.; Cheung W. W., Hwang G. Y., Tse E., Kwong Y. L. Alemtuzumab induced complete remission of autoimmune hemolytic anemia refractory to corticosteroids, splenectomy and rituximab. Haematologica 2006;91(5 Suppl):ECR13.; Crowther M., Chan Y. T., Garbett I. K. et al. Evidence-based focused review of the treatment of idiopathic warm immune hemolytic anemia in adults. Blood 2011;118(15):4036–40.; Faraci M., Zecca M., Pillon M. et al. Autoimmune hematological diseases after allogeneic hematopoietic stem cell transplantation in children: an Italian multicenter experience. Biol Blood Marrow Transplant 2014;20(2):272–8.; Flores G., Cunningham-Rundles C., Newland A. C., Bussel J. B. Efficacy of intravenous immunoglobulin in the treatment of autoimmune hemolyticanemia; results in 73 patients. Am J Hematol 1993;44(4):237–42.; Godder K., Pati A. R., Abhyankar S. H. et al. De novo chronic graft-versus-host disease presenting as hemolytic anemia following partially mismatched related donor bone marrow transplant. Bone Marrow Transplant 1997;19(8):813–7.; Iuchi Y., Kibe N., Tsunoda S. et al. Implication of oxidative stress as a cause of autoimmune hemolytic anemia in NZB mice. Free Radic Biol Med 2010;48(7):935–44.; Michel M. Classification and therapeutic approaches in autoimmune hemolytic anemia: an update. Expert Rev Hematol 2011;4(6):607–18.; O’Brien T. A., Eastlund T., Peters C. et al. Autoimmune haemolytic anaemia complicating haematopoietic cell transplantation in paediatric patients: high incidence and significant mortality in unrelated donor transplants for non-malignant diseases. Br J Haematol 2004;127(1):67–75.; O’Connell N., Goodyer M., Gleeson M. et al. Successful treatment with rituximab and mycophenolate mofetil of refractory autoimmune hemolytic anemia post-hematopoietic stem cell transplant for dyskeratosis congenita due to TINF2 mutation. Pediatr Transplant 2014;18(1):E22–4.; Perez-Andres M., Paiva B., Nieto W. G. et al.; Primary Health Care Group of Salamanca for the Study of MBL. Human peripheral blood B-cell compartments: a crossroad in B-cell traffic. Cytometry B Clin Cytom 2010;78 Suppl 1:S47–60.; Reddy P., Ferrara J. L. Immunobiology of acute graft-versus-host disease. Blood Rev 2003;17:187–94.; Saha M., Ray S., Kundu S., Chakrabarti P. Pure red cell aplasia following autoimmune hemolytic anemia: an enigma. J Postgrad Med 2013;59(1):51–3.; Sanz J., Arriaga F., Montesinos P. et al. Autoimmune hemolyticanemia following allogeneic hematopoietic stem cell transplantation in adult patients. Bone Marrow Transplant 2007:39(9):555–61.; Sevilla J., González-Vicent M., Madero L., Díaz M. A. Acute autoimmune hemolytic anemia following unrelated cord blood transplantation as an early manifestation of chronic graft-versus-host disease. Bone Marrow Transplant 2001;28(1):89–92.; Shlomchik W. D. Antigen presentation in graft-vs-host disease. Exp Hematol 2003;31(12):1187–97.; Stussi G., Halter J., Schanz U., Seebach J. D. ABO-histo blood group incompatibility in hematopoietic stem cell and solid organ transplantation. Transfus Apher Sci 2006;35(1):59–69.; Toriani-Terenzi C., Pozzetto U., Bianchi M., Fagiolo E. Cytokine network in autoimmune haemolytic anaemia: new probable targets for therapy. Cancer Detect Prev 2002;26(4):292–8.; Xu L., Zhang T., Liu Z. et al. Critical role of Th17 cells in development of autoimmune hemolytic anemia. Exp Hematol 2012;40(12):994–1004.; Zecca M., Nobili B., Ramenghi U. et al. Rituximab for the treatment of refractory autoimmune hemolytic anemia in children. Blood 2003;101(10):3857–61.; https://journal.nodgo.org/jour/article/view/17
-
4Academic Journal
Authors: Масчан, М., Хачатрян, Л., Скворцова, Ю., Курникова, Е., Шашелева, Д., Бобрынина, В., Балашов, Д., Скоробогатова, Е., Байдильдина, Д., Новичкова, Г., Масчан, А.
Subject Terms: ТРАНСПЛАНТАЦИЯ ГЕМОПОЭТИЧЕСКИХ СТВОЛОВЫХ КЛЕТОК, ЮВЕНИЛЬНЫЙ МИЕЛОМОНОЦИТАРНЫЙ ЛЕЙКОЗ, ТРАНСПЛАНТАЦИОННАЯ СМЕРТНОСТЬ, РЕЦИДИВ
File Description: text/html
-
5Academic Journal
Authors: Хачатрян, Л., Масчан, М., Самочатова, Е., Шнейдер, М., Байдильдина, Д., Солопова, Г., Сунцова, Е., Жарикова, Л., Петрова, У., Синицына, В., Новичкова, Г., Масчан, А.
Subject Terms: ДЕТИ, ЮВЕНИЛЬНЫЙ МИЕЛОМОНОЦИТАРНЫЙ ЛЕЙКОЗ, 13-ЦИС-РЕТИНОЕВАЯ КИСЛОТА, ДИФФЕРЕНЦИРОВОЧНАЯ ТЕРАПИЯ
File Description: text/html
-
6Academic Journal
Source: Онкогематология.
Subject Terms: ТРАНСПЛАНТАЦИЯ ГЕМОПОЭТИЧЕСКИХ СТВОЛОВЫХ КЛЕТОК, ЮВЕНИЛЬНЫЙ МИЕЛОМОНОЦИТАРНЫЙ ЛЕЙКОЗ, ТРАНСПЛАНТАЦИОННАЯ СМЕРТНОСТЬ, РЕЦИДИВ, 3. Good health
File Description: text/html
-
7Academic Journal
Source: Онкогематология.
Subject Terms: ДЕТИ, ЮВЕНИЛЬНЫЙ МИЕЛОМОНОЦИТАРНЫЙ ЛЕЙКОЗ, 13-ЦИС-РЕТИНОЕВАЯ КИСЛОТА, ДИФФЕРЕНЦИРОВОЧНАЯ ТЕРАПИЯ, 3. Good health
File Description: text/html
